Inceoglu; Ahmet Bora

Patent Applications and Registrations

Patent applications and USPTO patent grants for Inceoglu; Ahmet Bora.The latest application filed is for "methods of treating bone loss".

Company Profile

2.8.14

Inceoglu; Ahmet Bora - Davis CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of inhibiting pain Grant 10,813,894 - Hammock , et al. October 27, 2	2020-10-27
Methods Of Treating Bone Loss App 20200306232 - TRINDADE DA SILVA; Carlos Antonio ; et al.	2020-10-01
Potent soluble epdxide hydrolase inhibitors Grant 10,377,744 - Hammock , et al. A	2019-08-13
Methods Of Inhibiting Pain App 20180125803 - HAMMOCK; Bruce D. ; et al.	2018-05-10
Potent Soluble Epoxide Hydrolase Inhibitors App 20170174665 - Hammock; Bruce D. ; et al.	2017-06-22
Use of sEH inhibitors as analgesics Grant 9,119,837 - Hammock , et al. September 1, 2	2015-09-01
Alleviating neuropathic pain with EETs and sEH inhibitors Grant 8,399,425 - Hammock , et al. March 19, 2	2013-03-19
Modulation Of Bioactive Epoxy-fatty Acid Levels By Phosphodiesterase Inhibitors App 20130065936 - Hammock; Bruce D. ; et al.	2013-03-14
USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS App 20130045172 - Hammock; Bruce D. ; et al.	2013-02-21
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors Grant 8,263,651 - Hammock , et al. September 11, 2	2012-09-11
Inhibitors Of Soluble Epoxide Hydrolase To Inhibit Or Prevent Niacin-induced Flushing App 20120046251 - Schaefer; Saul ; et al.	2012-02-23
ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP App 20110230504 - Hammock; Bruce D. ; et al.	2011-09-22
Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors Grant 7,951,831 - Hammock , et al. May 31, 2	2011-05-31
Use Of Inhibitors Of Soluble Epoxide Hydrolase To Synergize Activity Of Cox And 5-lox Inhibitors App 20100286222 - Hammock; Bruce D. ; et al.	2010-11-11
Alleviating Neuropathic Pain With Eets And Seh Inhibitors App 20100267807 - Hammock; Bruce D. ; et al.	2010-10-21
Use Of Cis-epoxyeicosatrienoic Acids And Inhibitors Of Soluble Epoxide Hydrolase To Treat Conditions Mediated By Pbr, Cb2, And Nk2 Receptors App 20100074852 - Hammock; Bruce D. ; et al.	2010-03-25
Use of Seh Inhibitors as Analgesics App 20080249055 - Hammock; Bruce D. ; et al.	2008-10-09
Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors App 20060178347 - Hammock; Bruce D. ; et al.	2006-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.